Life Technologies Corporation (LIFE)
-NasdaqGS 74.04 
0.10(0.14%) 4:00PM EDT|After Hours
:
74.04 0.00 (0.00%) 4:20PM EDT
| Prev Close: | 73.94 |
|---|
| Open: | 73.91 |
|---|
| Bid: | 50.00 x 100 |
|---|
| Ask: | 75.90 x 300 |
|---|
| 1y Target Est: | 73.12 |
|---|
| Beta: | 1.28 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 73.83 - 74.07 |
|---|
| 52wk Range: | 39.73 - 74.33 |
|---|
| Volume: | 3,160,498 |
|---|
| Avg Vol (3m): | 3,612,370 |
|---|
| Market Cap: | 12.74B |
|---|
| P/E (ttm): | 31.35 |
|---|
| EPS (ttm): | 2.36 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Life Reaches New 52-Week High (LIFE)at TheStreet(Wed, May 22)
- Roche, Sigma-Aldrich teamed for Life bid, Reuters saystheflyonthewall.com(Tue, May 21)
- Roche, Sigma teamed up for failed Life Technologies bid: sourcesat Reuters(Tue, May 21)
- Roche, Sigma teamed up for failed Life Technologies bid -sourcesat Reuters(Tue, May 21)
- Opportunities in Hepatitis C and Genomic Technologies: a Wall Street Transcript Interview with David Ferreiro, Executive Director and Senior Analyst at Oppenheimer & Co. Inc.Wall Street Transcript(Tue, May 21)
- Thermo Fisher A Decent Long-Term Opportunityat Seeking Alpha(Tue, May 21)
- Life Technologies Corp Stock Buy Recommendation Reiterated (LIFE)at TheStreet(Tue, May 21)
- Life Technologies Announces Regulatory Approval of its 3500 Dx Series Genetic Analyzers in CanadaCNW Group(Mon, May 20)
- Diversify Into Singapore Dollars And Get 4% Yields With High Quality Baa3 Rated Bondsat Seeking Alpha(Fri, May 17)
- Gene-Testing Dispute Focuses on How Much a Patient Should Knowat Bloomberg(Thu, May 16)
- Zacks Industry Outlook Highlights: Life Technologies, Thermo Fisher Scientific, Bayer, Conceptus and Becton, Dickinson and Co.Zacks(Thu, May 16)
- The Hidden Opportunity of the Novel Coronavirusat Motley Fool(Wed, May 15)
- New Ion PGM™ Solution Outperforms Competitor on Major Performance Metrics for Benchtop SequencingPR Newswire(Tue, May 14)
- This Biotech Giant Is Continuing Its Growth via M&Aat Motley Fool(Mon, May 13)
- Enzo Biochem's Intellectual Property Protection To Attract Investor Attention In 2013at Seeking Alpha(Mon, May 13)
Key Statistics
| Forward P/E (1 yr): | 15.89 |
|---|
| P/S (ttm): | 3.33 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 4.22 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.96 |
|---|
| Mean Recommendation*: | 3.0 |
|---|
| PEG Ratio (5 yr expected): | 1.77 |
|---|
Business Summary
Life Technologies Corporation operates as a life sciences company. The companys Research Consumables business group offers molecular and cell biology reagents, endpoint PCR, and other benchtop instruments and consumables, such as RNAi, DNA s...
View More